Terrie Curran, President and Chief Executive at Phathom Pharmaceuticals, Inc. (PHAT), sold 23,026 shares at $44.08 ($998K) on 2021-03-22, disclosed to the SEC on 2021-03-23.
Open-market sale of $998k PHAT by President and Chief Executive. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $43.24 | 10,373 | $449K | 45.0% |
| 2 | $43.24 | 10,373 | $449K | 45.0% |
| 3 | $44.08 | 1,140 | $50K | 5.0% |
| 4 | $44.08 | 1,140 | $50K | 5.0% |
| Total | $43.32 avg | 23,026 | $998K | 100% |
| Filing → |
| PHAT | SELL | 2025-01-23 | $252K | — | Filing → |
| ARQT | SELL | 2024-11-13 | $189K | — | Filing → |
| PHAT | SELL | 2024-07-17 | $793K | — | Filing → |